PSA

You have access
An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients
HECTOR HUGO FURINI, KEVIN SANTIAGO DE SOUZA QUENZO FUKUSHIMA, MONYSE DE NÓBREGA, MARILESIA FERREIRA DE SOUZA, MILENE ROLDÃO SOUZA RODRIGUES, BEATRIZ BOCATTE DE MATTOS, ROBERTA LOSI GUEMBAROVSKI, PAULO EMÍLIO FUGANTI, ANDREA NAME COLADO SIMÃO, TAMIRES FLAUZINO and ILCE MARA DE SYLLOS CÓLUS

Anticancer Research January 2023, 43 (1) 369-379; DOI: https://doi.org/10.21873/anticanres.16172
Open Access
Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase
QINGHONG HAN and ROBERT M. HOFFMAN

Anticancer Research April 2021, 41 (4) 1921-1926; DOI: https://doi.org/10.21873/anticanres.14958
You have access
Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient
QINGHONG HAN, YUYING TAN and ROBERT M. HOFFMAN

Anticancer Research May 2020, 40 (5) 2813-2819; DOI: https://doi.org/10.21873/anticanres.14254
You have access
Outcome of Patients with Metastatic Castration-resistant Prostate Cancer After PSA Progression with Abiraterone Acetate
SHENG-CHUN HUNG, SHIAN-SHIANG WANG, JIAN-RI LI, MEI-CHIH CHEN, CHENG-KUANG YANG, CHUAN-SHU CHEN, HAO-CHUNG HO, KUN-YUAN CHIU, CHEN-LI CHENG, CHAO-HSIANG CHANG and YEN-CHUAN OU

Anticancer Research September 2018, 38 (9) 5429-5436; DOI: https://doi.org/10.21873/anticanres.12874
You have access
¹⁸F-Fluorocholine PET/MRI in Restaging of Prostatic Carcinoma in Relation to PSA Level and Detection of Active Disease
JIŘÍ FERDA, EVA FERDOVÁ, JAN BAXA, JINDŘICH FÍNEK and ONDŘEJ TOPOLČAN

Anticancer Research July 2018, 38 (7) 4139-4143; DOI: https://doi.org/10.21873/anticanres.12705
You have access
Proteins Annexin A2 and PSA in Prostate Cancer Biopsies Do Not Predict Biochemical Failure
DAVID S. LAMB, SVEN SONDHAUSS, JONATHAN C. DUNNE, LISA WOODS, BRETT DELAHUNT, PETER FERGUSON, JUDITH MURRAY, JOHN N. NACEY, JAMES W. DENHAM and T. WILLIAM JORDAN

Anticancer Research December 2017, 37 (12) 6943-6946;
You have access
Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer
VLASTIMIL KULDA, ONDREJ TOPOLCAN, RADEK KUCERA, MICHAELA KRIPNEROVA, KRISTYNA SRBECKA, MILAN HORA, ONDREJ HES, JIRI KLECKA, VACLAV BABUSKA, MILENA ROUSAROVA, VERONIKA BENSON and MARTIN PESTA

Anticancer Research September 2016, 36 (9) 4787-4793;
You have access
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature
SALVATORE GRISANTI, ALESSANDRO ANTONELLI, MICHELA BUGLIONE, CAMILLO ALMICI, CHIARA FORONI, MARIO SODANO, LUCA TRIGGIANI, DIANA GRECO, CARLOTTA PALUMBO, MIRELLA MARINI, STEFANO M. MAGRINI, ALFREDO BERRUTI and CLAUDIO SIMEONE

Anticancer Research June 2016, 36 (6) 2975-2981;
You have access
PHI in the Early Detection of Prostate Cancer
RADKA FUCHSOVA, ONDREJ TOPOLCAN, JINDRA WINDRICHOVA, MILAN HORA, OLGA DOLEJSOVA, LADISLAV PECEN, PETR KASIK, JAROSLAV NOVAK, MIROSLAVA CASOVA and JIRI SMEJKAL

Anticancer Research September 2015, 35 (9) 4855-4857;
You have access
Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥85 Year-old Patients with Advanced Castrate-resistant Prostate Cancer
ROBERTO PETRIOLI, EDOARDO FRANCINI, ANNA IDA FIASCHI, LETIZIA LAERA, SALVATORA TINDARA MIANO, GIOVANNI DE RUBERTIS and GIANDOMENICO ROVIELLO

Anticancer Research May 2015, 35 (5) 3097-3102;

Main menu

User menu

Search

PSA

Pages